Cargando…
A Compound Heterozygous Mutation of Lipase Maturation Factor 1 is Responsible for Hypertriglyceridemia of a Patient
Aim: Dyslipidemia is the most common lipid metabolism disorder in humans, and its etiology remains elusive. Hypertriglyceridemia (HTG) is a type of dyslipidemia that contributes to atherosclerosis and coronary heart disease. Previous studies have demonstrated that mutations in lipoprotein lipase (LP...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japan Atherosclerosis Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365152/ https://www.ncbi.nlm.nih.gov/pubmed/29910226 http://dx.doi.org/10.5551/jat.44537 |
_version_ | 1783393371036844032 |
---|---|
author | Liu, Yihui Xu, Jiang Tao, Wanyun Yu, Rong Zhang, Xinjiang |
author_facet | Liu, Yihui Xu, Jiang Tao, Wanyun Yu, Rong Zhang, Xinjiang |
author_sort | Liu, Yihui |
collection | PubMed |
description | Aim: Dyslipidemia is the most common lipid metabolism disorder in humans, and its etiology remains elusive. Hypertriglyceridemia (HTG) is a type of dyslipidemia that contributes to atherosclerosis and coronary heart disease. Previous studies have demonstrated that mutations in lipoprotein lipase (LPL), apolipoprotein CII (APOC2), apolipoprotein AV (APOA5), glycosylphosphatidylinositol anchored high-density lipoprotein-binding protein 1 (GPIHBP1), lipase maturation factor 1 (LMF1), and glycerol-3 phosphate dehydrogenase 1 (GPD1) are responsible for HTG by using genomic microarrays and next-generation sequencing. The aim of this study was to identify genetic lesions in patients with HTG. Method: Our study included a family of seven members from Jiangsu province across three generations. The proband was diagnosed with severe HTG, with a plasma triglyceride level of 38.70 mmol/L. Polymerase chain reaction (PCR) and Sanger sequencing were performed to explore the possible causative gene mutations for this patient. Furthermore, we measured the post-heparin LPL and hepatic lipase (HL) activities using an antiserum inhibition method. Results: A compound heterozygous mutation in the LMF1 gene (c.257C > T/p.P86L and c.1184C > T/p. T395I) was identified and co-segregated with the affected patient in this family. Both mutations were predicted to be deleterious by three bioinformatics programs (Polymorphism Phenotyping-2, Sorting Intolerant From Tolerant, and MutationTaster). The levels of the plasma post-heparin LPL and HL activities in the proband (57 and 177 mU/mL) were reduced to 24% and 75%, respectively, compared with those assayed in the control subject with normal plasma triglycerides. Conclusion: A compound heterozygous mutation of LMF1 was identified in the presenting patient with severe HTG. These findings expand on the spectrum of LMF1 mutations and contribute to the genetic diagnosis and counseling of families with HTG. |
format | Online Article Text |
id | pubmed-6365152 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Japan Atherosclerosis Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-63651522019-02-08 A Compound Heterozygous Mutation of Lipase Maturation Factor 1 is Responsible for Hypertriglyceridemia of a Patient Liu, Yihui Xu, Jiang Tao, Wanyun Yu, Rong Zhang, Xinjiang J Atheroscler Thromb Original Article Aim: Dyslipidemia is the most common lipid metabolism disorder in humans, and its etiology remains elusive. Hypertriglyceridemia (HTG) is a type of dyslipidemia that contributes to atherosclerosis and coronary heart disease. Previous studies have demonstrated that mutations in lipoprotein lipase (LPL), apolipoprotein CII (APOC2), apolipoprotein AV (APOA5), glycosylphosphatidylinositol anchored high-density lipoprotein-binding protein 1 (GPIHBP1), lipase maturation factor 1 (LMF1), and glycerol-3 phosphate dehydrogenase 1 (GPD1) are responsible for HTG by using genomic microarrays and next-generation sequencing. The aim of this study was to identify genetic lesions in patients with HTG. Method: Our study included a family of seven members from Jiangsu province across three generations. The proband was diagnosed with severe HTG, with a plasma triglyceride level of 38.70 mmol/L. Polymerase chain reaction (PCR) and Sanger sequencing were performed to explore the possible causative gene mutations for this patient. Furthermore, we measured the post-heparin LPL and hepatic lipase (HL) activities using an antiserum inhibition method. Results: A compound heterozygous mutation in the LMF1 gene (c.257C > T/p.P86L and c.1184C > T/p. T395I) was identified and co-segregated with the affected patient in this family. Both mutations were predicted to be deleterious by three bioinformatics programs (Polymorphism Phenotyping-2, Sorting Intolerant From Tolerant, and MutationTaster). The levels of the plasma post-heparin LPL and HL activities in the proband (57 and 177 mU/mL) were reduced to 24% and 75%, respectively, compared with those assayed in the control subject with normal plasma triglycerides. Conclusion: A compound heterozygous mutation of LMF1 was identified in the presenting patient with severe HTG. These findings expand on the spectrum of LMF1 mutations and contribute to the genetic diagnosis and counseling of families with HTG. Japan Atherosclerosis Society 2019-02-01 /pmc/articles/PMC6365152/ /pubmed/29910226 http://dx.doi.org/10.5551/jat.44537 Text en 2019 Japan Atherosclerosis Society This article is distributed under the terms of the latest version of CC BY-NC-SA defined by the Creative Commons Attribution License.http://creativecommons.org/licenses/by-nc-sa/3.0/ |
spellingShingle | Original Article Liu, Yihui Xu, Jiang Tao, Wanyun Yu, Rong Zhang, Xinjiang A Compound Heterozygous Mutation of Lipase Maturation Factor 1 is Responsible for Hypertriglyceridemia of a Patient |
title | A Compound Heterozygous Mutation of Lipase Maturation Factor 1 is Responsible for Hypertriglyceridemia of a Patient |
title_full | A Compound Heterozygous Mutation of Lipase Maturation Factor 1 is Responsible for Hypertriglyceridemia of a Patient |
title_fullStr | A Compound Heterozygous Mutation of Lipase Maturation Factor 1 is Responsible for Hypertriglyceridemia of a Patient |
title_full_unstemmed | A Compound Heterozygous Mutation of Lipase Maturation Factor 1 is Responsible for Hypertriglyceridemia of a Patient |
title_short | A Compound Heterozygous Mutation of Lipase Maturation Factor 1 is Responsible for Hypertriglyceridemia of a Patient |
title_sort | compound heterozygous mutation of lipase maturation factor 1 is responsible for hypertriglyceridemia of a patient |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365152/ https://www.ncbi.nlm.nih.gov/pubmed/29910226 http://dx.doi.org/10.5551/jat.44537 |
work_keys_str_mv | AT liuyihui acompoundheterozygousmutationoflipasematurationfactor1isresponsibleforhypertriglyceridemiaofapatient AT xujiang acompoundheterozygousmutationoflipasematurationfactor1isresponsibleforhypertriglyceridemiaofapatient AT taowanyun acompoundheterozygousmutationoflipasematurationfactor1isresponsibleforhypertriglyceridemiaofapatient AT yurong acompoundheterozygousmutationoflipasematurationfactor1isresponsibleforhypertriglyceridemiaofapatient AT zhangxinjiang acompoundheterozygousmutationoflipasematurationfactor1isresponsibleforhypertriglyceridemiaofapatient AT liuyihui compoundheterozygousmutationoflipasematurationfactor1isresponsibleforhypertriglyceridemiaofapatient AT xujiang compoundheterozygousmutationoflipasematurationfactor1isresponsibleforhypertriglyceridemiaofapatient AT taowanyun compoundheterozygousmutationoflipasematurationfactor1isresponsibleforhypertriglyceridemiaofapatient AT yurong compoundheterozygousmutationoflipasematurationfactor1isresponsibleforhypertriglyceridemiaofapatient AT zhangxinjiang compoundheterozygousmutationoflipasematurationfactor1isresponsibleforhypertriglyceridemiaofapatient |